Table 33:
Estimated Annual Per-Patient Costs of Continuous Glucose Monitoring when Insulin Pump, Insulin, and 75% of Sensor Costs Are Publicly Funded
| Intervention | Technology | Year 1, $ | Year 2, $ | Year 3, $ | Year 4, $ | Year 5, $ |
|---|---|---|---|---|---|---|
| Comparators | ||||||
| SMBG + multiple daily injections | — | 2,329 | 2,692 | 2,952 | 3,134 | 3,251 |
| SMBG + insulin pump | Animas Vibe | 1,599 | 1,963 | 2,234 | 2,432 | 2,566 |
| Interventions | ||||||
| CGM + multiple daily injections | Dexcom G4/G5 | 6,889a | 7,240a | 7,389a | 7,461a | 7,465a |
| CGM + insulin pump | Integrated | 5,542b | 5,893b | 6,058b | 6,157b | 6,194b |
| SAP with LGS | MiniMed Veo | 3,406 | 3,725 | 3,959 | 4,112 | 4,199 |
| SAP or SAP with LGS | 10% SAP; 90% SAP with LGS | 3,619 | 3,942 | 4,169 | 4,317 | 4,399 |
| Average CGM device | 40% CGM + multiple daily injections; 60% CGM + SAP | 4,927 | 5,261 | 5,457 | 5,574 | 5,625 |
Abbreviations: CGM, continuous glucose monitoring; LGS, low-glucose suspend [feature]; SAP, sensor-augmented pump; SMBG, self-monitoring of blood glucose.
a
Average cost of Dexcom G4 Platinum and Dexcom G5 Mobile.
b
Average cost of Dexcom G4 Platinum + Animas Vibe and Dexcom G5 Mobile + Animas Vibe.